Atlas Trials

Non-muscle Invasive Bladder Cancer (NMIBC)

25 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-muscle Invasive Bladder Cancer (NMIBC)

RecordFirmDate
Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test (NCT05176145)Vitadx2022-04-05
Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC. (NCT06069453)Fidia Farmaceutici s.p.a.2020-08-19
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment (NCT04179162)Memorial Sloan Kettering Cancer Center2019-11-22
Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors (NCT03839472)Case Comprehensive Cancer Center2019-09-01
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC (NCT03719300)Anchiano Therapeutics Israel Ltd.2019-03-20
Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment (NCT03672240)Asieris Pharmaceutical Technologies Co., Ltd.2018-11-30
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT03167151)University of Oxford2018-03-02
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident (NCT03148158)Mansoura University2018-01-15
Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? (NCT03038321)Mansoura University2017-02-01
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer (NCT02009332)Aadi Bioscience, Inc.2014-04-09

Track Non-muscle Invasive Bladder Cancer (NMIBC) automatically

Every clearance here is in the API, with alerts when new ones post.